IBOC stock forecast, quote, news & analysis

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where IBOC's RSI Oscillator exited the oversold zone, 9 of 17 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 53%.

The Moving Average Convergence Divergence (MACD) for IBOC just turned positive on October 23, 2026. Looking at past instances where IBOC's MACD turned positive, the stock continued to rise in 35 of 51 cases over the following month. The odds of a continued upward trend are 69%.

Following a +3.02% 3-day Advance, the price is estimated to grow further. Considering data from situations where IBOC advanced for three days, in 186 of 300 cases, the price rose further within the following month. The odds of a continued upward trend are 62%.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 39 of 65 cases where IBOC's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 60%.

IBOC moved below its 50-day moving average on November 05, 2026 date and that indicates a change from an upward trend to a downward trend.

The 50-day moving average for IBOC moved below the 200-day moving average on October 13, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IBOC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 54%.

IBOC broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for IBOC entered a downward trend on October 29, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 14 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 22 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 56, placing this stock better than average.

The Tickeron PE Growth Rating for this company is 39 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 56 (best 1 - 100 worst), indicating fairly steady price growth. IBOC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 66 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.246) is normal, around the industry mean (1.262). P/E Ratio (10.181) is within average values for comparable stocks, (13.480). Projected Growth (PEG Ratio) (0.350) is also within normal values, averaging (1.194). Dividend Yield (0.043) settles around the average of (0.035) among similar stocks. P/S Ratio (5.141) is also within normal values, averaging (3.740).